Immune Profile and MRI-Detected Cardiac Fibrosis and Edema in Hypertensive and Non-Hypertensive Patients with COVID-19

article
Autores

Moll-Bernardes, Renata

Camargo, Gabriel C.

Silvestre-Sousa, Andréa

Barroso, Julia Machado

Ferreira, Juliana R.

Tortelly, Mariana B.

Pimentel, Adriana L.

Figueiredo, Ana Cristina B. S.

Schaustz, Eduardo B.

Secco, José Carlos P.

Fortier, Sergio C.

Vera, Narendra

Conde, Luciana

Cabral-Castro, Mauro Jorge

Albuquerque, Denilson C.

Rosado-de-Castro, Paulo H.

Pinheiro, Martha V. T.

Souza, Olga F.

Luiz, Ronir R.

Medei, Emiliano

Data de Publicação

2 de dezembro de 2024

Resumo

Cardiac involvement in 2019 coronavirus disease (COVID-19) survivors has been reported frequently. An exacerbated immune response may be the main mechanism of myocardial injury and late cardiac sequelae in this population. Background/Objectives: We investigated the immune profile in hypertensive and non-hypertensive patients with COVID-19 who developed late cardiac fibrosis and edema, as detected by magnetic resonance imaging (MRI). Methods: We evaluated associations of cytokine and immune-cell subset levels during hospitalization for COVID-19 with the presence of myocardial interstitial fibrosis [represented by the extracellular volume (ECV)] or edema (represented by the T2), detected by cardiac MRI examination after discharge, in hypertensive and non-hypertensive patients. Results: Patients with hypertension had reduced B-cell percentages, increased natural killer cell percentages, and higher interleukin (IL)-4, IL-5, IL-13, IL-17A, and tumor necrosis factor-β levels compared to patients without hypertension. Larger percentages of human leukocyte antigen DR isotope+ blood cells, reflecting CD8+ T-cell activation, correlated with increased T2 and ECV in hypertensive patients. The HLA-DR mean fluorescence intensity was associated with ECV in non-hypertensive patients. Conclusions: Our findings reveal cytokine and immune-cell dysregulation in both hypertensive and non-hypertensive patients with COVID-19, along with moderate correlations between CD8+ T-cell activation and increased cardiac MRI markers of myocardial interstitial fibrosis and edema. These results contribute to a deeper understanding of immune dysfunction mechanisms involved in myocardial remodeling.

Citação

BibTeX
@online{renata2024,
  author = {Renata , Moll-Bernardes and Gabriel C. , Camargo and Andréa
    , Silvestre-Sousa and Julia Machado , Barroso and Juliana R. ,
    Ferreira and Mariana B. , Tortelly and Adriana L. , Pimentel and Ana
    Cristina B. S. , Figueiredo and Eduardo B. , Schaustz and José
    Carlos P. , Secco and Sergio C. , Fortier and Narendra , Vera and
    Luciana , Conde and Mauro Jorge , Cabral-Castro and Denilson C. ,
    Albuquerque and Paulo H. , Rosado-de-Castro and Martha V. T. ,
    Pinheiro and Olga F. , Souza and Ronir R. , Luiz and Emiliano ,
    Medei},
  title = {Immune Profile and MRI-Detected Cardiac Fibrosis and Edema in
    Hypertensive and Non-Hypertensive Patients with COVID-19},
  volume = {13},
  number = {23},
  date = {2024-12-02},
  doi = {10.3390/jcm13237317},
  langid = {pt-BR},
  abstract = {Cardiac involvement in 2019 coronavirus disease (COVID-19)
    survivors has been reported frequently. An exacerbated immune
    response may be the main mechanism of myocardial injury and late
    cardiac sequelae in this population. Background/Objectives: We
    investigated the immune profile in hypertensive and non-hypertensive
    patients with COVID-19 who developed late cardiac fibrosis and
    edema, as detected by magnetic resonance imaging (MRI). Methods: We
    evaluated associations of cytokine and immune-cell subset levels
    during hospitalization for COVID-19 with the presence of myocardial
    interstitial fibrosis {[}represented by the extracellular volume
    (ECV){]} or edema (represented by the T2), detected by cardiac MRI
    examination after discharge, in hypertensive and non-hypertensive
    patients. Results: Patients with hypertension had reduced B-cell
    percentages, increased natural killer cell percentages, and higher
    interleukin (IL)-4, IL-5, IL-13, IL-17A, and tumor necrosis factor-β
    levels compared to patients without hypertension. Larger percentages
    of human leukocyte antigen DR isotope+ blood cells, reflecting CD8+
    T-cell activation, correlated with increased T2 and ECV in
    hypertensive patients. The HLA-DR mean fluorescence intensity was
    associated with ECV in non-hypertensive patients. Conclusions: Our
    findings reveal cytokine and immune-cell dysregulation in both
    hypertensive and non-hypertensive patients with COVID-19, along with
    moderate correlations between CD8+ T-cell activation and increased
    cardiac MRI markers of myocardial interstitial fibrosis and edema.
    These results contribute to a deeper understanding of immune
    dysfunction mechanisms involved in myocardial remodeling.}
}
Por favor, cite este trabalho como:
Renata, Moll-Bernardes, Camargo Gabriel C., Silvestre-Sousa Andréa, Barroso Julia Machado, Ferreira Juliana R., Tortelly Mariana B., Pimentel Adriana L., et al. 2024. “Immune Profile and MRI-Detected Cardiac Fibrosis and Edema in Hypertensive and Non-Hypertensive Patients with COVID-19.” Journal of Clinical Medicine. December 2, 2024. https://doi.org/10.3390/jcm13237317.